spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 9 Sep 2019
DePuy Synthes Expands ATTUNE Knee Platform with Cementless Option
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 9 Sep 2019
Zimmer Biomet Commences Commercial Release of Persona(R) Revision Knee System
Devices Orthopaedic FDA Product Launch
 HSMN NewsFeed - 9 Sep 2019
CollPlant Biotechnologies Closes on $5.5 Million Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 9 Sep 2019
Lilly Announces Positive Results for Selpercatinib (LOXO-292), Demonstrating a 68 Percent Objective Response Rate and Sustained Durability in Heavily Pretreated RET Fusion-Positive Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Sep 2019
Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor
Diagnostics Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 6 Sep 2019
Bardy Diagnostics(TM) Receives FDA 510(k) Clearance for 14-Day Carnation Ambulatory Monitor (CAM) Patch
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 6 Sep 2019
Occlutech AFR Heart Failure Device Obtains CE Mark Approval
Devices Cardiology Regulatory
 HSMN NewsFeed - 5 Sep 2019
Arthrosurface Receives FDA Clearance for BOSS(TM) Toe Fixation System
Devices Orthopaedic FDA
 HSMN NewsFeed - 4 Sep 2019
NW Bio Expands Senior Management Team With Dr. Kevin Duffy As Vice President, Medical Affairs & External Collaborations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Sep 2019
Kallyope Inc. Appoints Juha Lauren As Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2019
PolyPid Announces Completion of $50 Million Series E-1 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Sep 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Devices Regulatory
 HSMN NewsFeed - 4 Sep 2019
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 4 Sep 2019
Citius Announces Change To Primary Endpoint In Mino-Lok(R) Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2019
Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2019
Laboratory for Advanced Medicine Receives FDA Breakthrough Device Designation for Liquid Biopsy Liver Cancer Detection Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 3 Sep 2019
Dynacure Appoints David Garrett as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2019
MedShape Announces Commercial Launch of DynaNail Mini(TM) for Subtalar Fusion
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA
 HSMN NewsFeed - 3 Sep 2019
Endo Launches Authorized Generic Version of Noxafil(R) (posaconazole) Delayed-release Tablets in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 3 Sep 2019
Sony Announces Plans for the Next Generation of NUCLeUS, the Smart Imaging Platform for Hospitals
Devices Radiology
 HSMN NewsFeed - 3 Sep 2019
Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe
Biopharmaceuticals Venture Capital
More stories   Return to NewsFeed  
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.